Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease is a research paper published in EBioMedicine (2020). On theSindex it has a DataRank of 0. It has been cited 40 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R21NS 095047
National Institutes of Health
Grant: R01 NS 086134
National Institutes of Health
Grant: UH2 NS092981
NICHD NIH HHS
Grant: R21 HD102788
National Institutes of Health
Grant: 5R21NS095047-02
Intravenous Enzyme Replacement Therapy for CNS Disorders
National Institutes of Health
Grant: 1UH2NS092981-01
The Development of Small Molecule Inhibitors for Gaucher Disease Type 3
National Institutes of Health
Grant: 5R01NS086134-02
Gaucher disease:Treatment of neurodegenerative disease
FWCI
2.50
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals